Dave Rosa
2020
In 2020, Dave Rosa earned a total compensation of $1.1M as Chief Executive Officer and President at NEUROONE MEDICAL TECHNOLOGIES Corp, a 103% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $183,095 |
|---|---|
| Option Awards | $547,091 |
| Salary | $403,914 |
| Total | $1,134,100 |
Rosa received $547.1K in option awards, accounting for 48% of the total pay in 2020.
Rosa also received $183.1K in non-equity incentive plan and $403.9K in salary.
Rankings
In 2020, Dave Rosa's compensation ranked 8,089th out of 13,090 executives tracked by ExecPay. In other words, Rosa earned more than 38.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,089 out of 13,090 | 38th |
Division Manufacturing | 3,436 out of 5,620 | 39th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 436 out of 799 | 45th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 260 out of 495 | 48th |
Industry Surgical and Medical Instruments and Apparatus | 168 out of 313 | 46th |
Source: SEC filing on May 6, 2021.
Rosa's colleagues
We found two more compensation records of executives who worked with Dave Rosa at NEUROONE MEDICAL TECHNOLOGIES Corp in 2020.
News
NEUROONE MEDICAL TECHNOLOGIES Corp CEO Dave Rosa's 2023 pay slips 17% to $990K
January 29, 2024
NEUROONE MEDICAL TECHNOLOGIES Corp CEO Dave Rosa's 2022 pay falls 37% to $1.2M
January 27, 2023
NEUROONE MEDICAL TECHNOLOGIES Corp CEO Dave Rosa's 2021 pay jumps 67% to $1.9M
April 29, 2022
NEUROONE MEDICAL TECHNOLOGIES Corp CEO Dave Rosa's 2020 pay jumps 103% to $1.1M
May 6, 2021